English press releases

Takeda presenteert positieve gegevens van TOURMALINE-MM3, Eerste Pivotale fase 3 placebogecontroleerde test met evaluatie van de proteasoomremmende behandeling in de onderhoudsomgeving.

– Onderhoudstherapie met NINLARO™ (ixazomib) verbeterde progressievrije overleving bij volwassen patiënten met multipel myeloom na autologe stamceltransplantatie – – Gegevens worden gepresenteerd op de 60e...

Char Popp naar PSB als Senior Vice President en Global Head of Qualitative Research

WASHINGTON – (BUSINESS WIRE) – PSB, een op onderzoek gebaseerd wereldwijd consultancybureau, heeft vandaag aangekondigd dat Char Popp zich bij het bedrijf heeft aangesloten als...

Oxford BioMedica Notes the Longer-Term Analyses from Pivotal Kymriah® Trials, Which Showed Durable Responses Are Maintained in Patients with Advanced Blood Cancers

OXFORD, England–(BUSINESS WIRE)– Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group, today notes an announcement by Novartis...

Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018

Pivotal phase 3 data demonstrated treatment with investigational luspatercept resulted in significant reduction of transfusion burden compared to placebo Regulatory submissions planned in the United...

Celgene Corporation Announces Initial Phase 1/2 Liso-cel Data in Patients with Relapsed/Refractory CLL, Including Those with High-Risk Disease, Previously Treated with Ibrutinib, at ASH 2018

Eighty one percent overall response rate and 43% complete response rate observed in heavily pre-treated patients Majority of patients evaluable for minimal residual disease achieved...

Kite Announces Two-Year Data for Yescarta® (Axicabtagene Ciloleucel) in Patients With Refractory Large B-Cell Lymphoma

— 39 Percent of Patients in Ongoing Response Two Years after a Single Infusion of Yescarta in the ZUMA-1 Study; Median Overall Survival was Not...

Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 MEDALIST Trial Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session

Pivotal phase 3 data demonstrated treatment with investigational luspatercept resulted in statistically significant increased red blood cell transfusion independence compared to placebo Regulatory submissions planned...

European Medicines Agency Accepts Extension Marketing Authorisation Application for Review of Celltrion’s Remsima SC, the Subcutaneous Version of Remsima®

European Medicines Agency started to officially review ‘Remsima SC’; expecting European approval in the second half of next year INCHEON, South Korea–(BUSINESS WIRE)–Celltrion, Inc. (KRX:068270)...

NTT Communications Expands Its DDoS Protection Services with New Auto-Mitigation Solution

Global IP Network Customers Can Choose the Level of Mitigation Support that Best Fits their Cyber Security Strategy NEW YORK–(BUSINESS WIRE)–NTT Communications Corporation (NTT Com),...

Celgene Corporation Announces Results of AUGMENT Evaluating REVLIMID® In Combination with Rituximab (R2) In Patients with Relapsed/Refractory Indolent Lymphoma At ASH 2018

Pivotal phase 3 data show investigational R2 significantly extended progression-free survival compared with rituximab plus placebo Positive trend in overall survival was observed Regulatory submissions...

Een ongekend initiatief, gesteund door de Verenigde Arabische Emiraten

BOSTON–(BUSINESS WIRE)– De Raad van Arabische Economische Eenheid kondigt een gemeenschappelijke visie op de Arabische digitale economie aan “Een gemeenschappelijke visie op de Arabische digitale...

H.I.G. Capital investeert in wellness hotel in Duitsland

LONDON—(BUSINESS WIRE)– H.I.G. Capital, LLC (“H.I.G.”), een toonaangevende wereldwijde private equity investeringsmaatschappij met meer dan €26 miljard aan eigen vermogen onder beheer, kondigde vandaag aan...

Marriott Announces Starwood Guest Reservation Database Security Incident

BETHESDA, Md.–(BUSINESS WIRE)– Marriott has taken measures to investigate and address a data security incident involving the Starwood guest reservation database. On November 19, 2018, the...

Pacific Drilling kondigt derde kwartaal 2018 conferencecall aan

LUXEMBOURG–(BUSINESS WIRE)– Pacific Drilling S.A. (OTC: PACDDD) zal een persbericht uitgeven waarin de financiële resultaten voor het derde kwartaal, dat op maandag 3 december 2018,...

Tokyo Gas Switches to Rimini Street Support for SAP Applications

LAS VEGAS–(BUSINESS WIRE)– Leading energy provider in Japan maximizes ROI on key SAP system while receiving premium-level support Rimini Street, Inc. (Nasdaq: RMNI), a global provider...